To check for the linearity of aPL detection by LIA and the location of the cut-off on each aPL curve, we performed a serial dilution of a serum from an APS patient who was strongly positive for aCL IgG and aβ2GPI IgG by a commercial chemiluminescent assay. The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.